cells

GT Biopharma Inc

$GTBP 
Bottom line is the current Board &amp; CEO need to be removed by any legal means possible and as quickly as possible, and replaced by the best possible qualified &amp; motivated candidates.

They need to be fired immediately for incompetence, malfeasance, and stealing insanely high salaries &amp; company stock while the company stock has crashed on their watch!

$GTBP 
Breen &amp; the Board need to be replaced.

This current CEO &amp; Board do not seem to acknowledge retail investors which are the backbone of this company, right now anyway.

board

the board fails time and again only to reward themselves with more cash and options compensation. absurd.

$GTBP 
Fire the CEO and the incompetent Board, not Berk, you big dummies! !

As it is, the board needs to be replaced in full.

$GTBP 
New All Time Low Again
$1.46:
And the CEO Breen and the Board do nothing to stop the slide.

executive

$GTBP       the ceo Michael Breem is supposed to be “interim ceo” so fucking go away already and hire a ceo that will deliver.

There is NO transparency, the stock dropped down to the low 1’s, the management has missed deadlines that has pushed back on clinic, incompetence at many levels, and I understand the CEO doesn’t even live in this country.

All the management, from the CEO on down needs to be replaced.

shareholder

I urge all shareholders to call the proper authorities to investigate this total sham.

team

but the company management team really sucks.

$GTBP The market does not believe in this management team.

technology

Dr. Miller of course is great and his technology is tops in the field.

$GTBP The technology is second to none and they still have  Dr. Miller.

This technology is amazing and GTBP should be worth at least a billion dollars!

$GTBP 
This company has great technology, pipeline of products, and I.P.

ImmunityBio Inc

bottom

You slap it, it flies up and snaps back on its string to smack it on the bottom again. .but.

shit

$AMRS $IBRX boy I sure know how to pick absolute dog shit

Hate to know I was heavy in this shit..what a joke

$IBRX all chines stocks down nobody knows why and this shit

$IBRX greedy fucking banks and their over leveraged, non deliveries and short manipulation.

negative trend and losing 10 to 20 cents since last two weeks 
same shit same continuous pattern

approval

It has cost more money than expected and Anktiva approval is taking longer as well,

This process take up to 1 year to get approved ? 👇😡.

However, if there was any indication of denied or prolonged approval, wouldn‘t the company have to inform the marked immediately?

No approval in sight or anything like that.

$IBRX based on price action, either nobody believes in our success of approval or we are heavily manipulated.

Meanwhile patients suffer while the FDA works towards the May approval decision.

control

The regimen did not improve patients’ progression-free survival odds compared to the control and was less effective than chemo&quot; 
https://endpts.com/mercks-keytruda-plus-tigit-combo-proves-less-effective-than-chemo-in-open-label-lung-cancer-study/

Why would you put someone on a control arm with the same previous failed therapy again only to have that person die?

market

It could become a rough ride in the market.

$IBRX This value deterioration has been painful to experience and to watch unfold since it began in 2021 and more recently since 02/07/23 with roughly 21 consecutive market days of red ink.

$IBRX The market is in a slow motion crash.

PSS is going to have too dump millions upon millions of shares on the market every 3 months due primarily to his mismanagement.

Market massive and it hands down best Keytruda which is approved.

$IBRX if this is approved in May, the data looks great!

$IBRX Regardless of all the negatives that have been put forward by others in previous posts, an approval by the FDA will be a positive and definitely create a huge short squeeze.

Great buying opportunity here similar to a bio-run-up deal that you can make 100% and let the winnings ride on approval.

Basically, it dramatically lowers their risk, improves their liquidity and allows them to benefit if their is big movement due to some binary event like FDA approval while limiting their downside.

$IBRX The fact that vesanktiva was accepted bodes well for approval.

$IBRX Both waiting FDA approval, both have similar charts and Similar mkt caps: 
Market Cap 1.055B $RETA Market Cap 1.101B 
 
Short Games played till get FDA approval, gotta love the shakeouts.

share

$IBRX Own every share and not letting go!

Fits in well with the thousands of shares I have added since this short sale debacle last week .

but when the usual 9am Westcoast hedge fund dump didn&#39;t happen, I was happy to see share price going higher and higher

$IBRX Up 36.30% on 9,742,254 shares. Nice!

$IBRX virtually an endless supply of shares for 1.62 - endless 🤔

I’m not giving up one share and will continue adding at these levels.

The increase in capital for the company raised by selling additional shares of stock can finance additional company growth.

$IBRX mark your calendar, share price to the upside prior to this event, smart money is loading, stop bashing and make money for your family.

candlestick

$IBRX seems a nice setup in 5 minutes candle

$IBRX made a hammer on increasing positive volume, stochastics turned bullish and MACD ready to cross bullish.

but that&#39;s two Hammer candles in a few sessions things are looking up finally

but I believe the formation of a “hammer” is bullish and may be a signal for shorts to cover.

$IBRX looks like going gap at 2.32.bullish engulfing candle.🍻

gain

There is a nice gain to be made by closing that overhead gap created on JAN 4th  from $5.03 to $4.91.

$ibrx very nice today at 1.74 - team in at 1.22 for 43% gain so far

$IBRX superficial gains, all stocks are up, the dollar is down pricing all equities higher..

$IBRX The volume increased for a consecutive 5 days, with an average daily gain of 107%.

$IBRX In addition to the bullish symmetrical triangle that I posted about twice already there is another BREAKOUT attempt coming up again,  confirmed with a close above 6.66 😈(devils in the details) 😈 
 
Initial Target: 7.88, for a whopping 28%  gain.

Will put the gains into ibrx later this week 🫶👍🤙✌️

Sarepta has the largest percentage gain probability from here!

Frequency Therapeutics Inc

$LYT  on watch too 

Overall markets look like trash.

business-result

One day the results announcement was they were poor and the stock crashed 24 point s and 12 million shares sold that day.

So while I&#39;m hoping and praying for these next results, be careful with your money on this one.

investor

Then the scumbag management decided to sodomize investors by dropping this news.

management

$FREQ still silence from management, what a shame

pump-and-dump

$FREQ yikes, quite the dump, somebody wanted out tired of waiting?

The difference today is the low stock price and the large upside potential when good results get announced.

Considering the 9 years already passed - this quick and positive result seems to be a likely scenario.

But the stock has been as high as $56 and it definitely will show positive results.

but I’m getting pretty excited for results.

I still feel confident that we will see positive results from the 2b study.

$FREQ who is following FREQ from the IPO deserve positive results for FX-322…

So the way this study is designed (work recognition) should prove positive results.

$FREQ this is going to reach way about 55 if positive results.

Let’s just steadily gain as we approach results.

bounce

Looking forward to see this bounce in the next week and reach new highs.

300k float with big bounce of 52w lows and looking good for continuation today!. .

split

cash

The science is sound, good cash position, and Regeneron continues to pay up maintaining its partnership collaboration.

Top Stocks matching your search for "cells inside"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

GTBP

GT Biopharma Inc

-38.01%

$0.91 - $0.56

Dec, 7, 2022

IBRX

ImmunityBio Inc

-57.41%

$4.32 - $1.84

Nov, 22, 2022

Discover Your Wealth Potential with Stock Advisor

FREQ

Frequency Therapeutics Inc

-88.29%

$4.15 - $0.49

Jan, 12, 2023

GTBP

GT Biopharma Inc

-38.01%

$0.91 - $0.56

Dec, 7, 2022

IBRX

ImmunityBio Inc

-57.41%

$4.32 - $1.84

Nov, 22, 2022

FREQ

Frequency Therapeutics Inc

-88.29%

$4.15 - $0.49

Jan, 12, 2023